Likewise, FX supplementation (0.1 and 0.2%) prevented obesity development and reduced hyperglycemia in diabetic/obese KK-Ay mice, by supressing MCP-1 and TNF-α, which are involved in insulin resistance [286]. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.